title: Cancer epigenetics: an introduction.
abstract: Epigenetic and genetic alterations contribute to cancer initiation and progression. Epigenetics refers to the study of heritable changes in gene expression without alterations in DNA sequences. Epigenetic changes are reversible and include key processes of DNA methylation, chromatin modifications, nucleosome positioning, and alterations in noncoding RNA profiles. Disruptions in epigenetic processes can lead to altered gene function and cellular neoplastic transformation. Epigenetic modifications precede genetic changes and usually occur at an early stage in neoplastic development. Recent technological advances offer a better understanding of the underlying epigenetic alterations during carcinogenesis and provide insight into the discovery of putative epigenetic biomarkers for detection, prognosis, risk assessment, and disease monitoring. In this chapter we provide information on various epigenetic mechanisms and their role in carcinogenesis, in particular, epigenetic modifications causing genetic changes and the potential clinical impact of epigenetic research in the future.
authors.affiliation: Department of Urology, Case Western Reserve University, 10900 Euclid Avenue, Cleveland, OH, 44106, USA.
authors.forename: Rajnee
authors.initials: R
authors.lastname: Kanwal
authors.forename: Karishma
authors.initials: K
authors.lastname: Gupta
authors.forename: Sanjay
authors.initials: S
authors.lastname: Gupta
mesh_terms: D000818:Animals; D014408:Biomarkers, Tumor / Q000235:genetics; D044127:Epigenesis, Genetic; D057890:Epigenomics; D006801:Humans; D009369:Neoplasms / Q000235:genetics* / Q000517:prevention & control / Q000628:therapy
chemical_list: D014408:Biomarkers, Tumor